High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).

Key Points

• Bleeding time increased with high-dose erythropoietin administration, showing a significant alteration in platelet reactivity.
• Platelet reactivity was notably different between high-dose erythropoietin and its neuroprotective variant carbamyl-erythropoietin.
• This analysis was performed on rodent models, allowing insights into the impacts on bleeding dynamics.
• These findings highlight the need for careful consideration of erythropoietin dosage in therapeutic settings.